Enter your login e-mail to the account
Search
Search parameters
Search results
- The management of non-alcoholic fatty liver disease
prof. MUDr. Jozef Holomáň, CSc., doc. MUDr. Mária Szántová, PhD., Doc. MUDr. Martin Zima, PhD., PharmDr. Ľubica Slobodová
(5/2016, Topic of the year ) - Hypolipidemic treatment of patients with nonalcoholic fatty liver disease
doc. MUDr. Peter Jarčuška, PhD., MUDr. Martin Janičko, MUDr. Eduard Veseliny, MUDr. Ján Fedačko, MUDr. Božena Nováková, prof. MUDr. Daniel Pella, CSc.
(6/2010, Topic of the year ) - Coagulopathy associated with COVID-19 infection Safe and effective thromboprophylaxis is essential for patient survival
MUDr. Ľubomíra Romanová, PhD., MUDr. Erika Palenčíková, MUDr. Martin Kováč
(3/2021, Interdisciplinary consilium ) - Diagnosis of acute pancreatitis
doc. MUDr. Ladislav Kužela, CSc.
(3/2011, Review articles )
- Depression in anxiety disorders
prof. MUDr. Eva Češková, CSc.
(2/2013, Review articles ) - Mental disorders – epigenetic mechanisms in their etiology and pharmacotherapy
MUDr. Bc. Libor Ustohal, Ph.D., prof. MUDr. Ladislav Hosák, Ph.D., doc. MUDr. Klára Látalová, Ph.D., RNDr. Aleš Kovařík, CSc.
(1/2016, Review articles ) - Chronic Fatigue Syndrome
doc. MUDr. Ladislav Steidl
(1/2002, Review articles ) - What prevents more successful pharmacological treatment of depressive disorder?
MUDr. Petr Šilhán, Ph.D., MUDr. Martin Hýža, MUDr. Tomáš Skřont, Mgr. Jan Vantuch
(2/2021, Review articles ) - Alzheimer’s disease as a neuropathological continuum in clinical practice. How did we improve the diagnosis since 1984 and why we don’t have a causal therapy yet?
MUDr. Kateřina Sheardová, MUDr. Daniel Hudeček, MUDr. Olga Hromková, Ph.D., Rafal Marciniak, prof. MUDr. Jakub Hort, Ph.D.
(2/2017, Review articles ) - Biomarkers of schizophrenia – a brief review and the recent knowledge
prof. MUDr. Ladislav Hosák, Ph.D.
(3/2016, Review articles )
- Profile of a patient with secondary progressive MS – how to identify patients that should be sent to a tertiary Center
MUDr. Hana Mojžišová, MUDr. Martin Elišák, Ph.D.
(5/2021, Review articles ) - Multiple sclerosis: treatment, monitoring, activity and disability
MUDr. Zbyšek Pavelek, doc. MUDr. Martin Vališ, Ph.D.
(4/2018, Review articles ) - New treatment options for Neuromyelitis optica spectrum disorders (NMOSD)
prof. MUDr. Jarmila Szilasiová, PhD.
(3/2024, Review articles ) - Proton MR spectroscopy in neurooncology
doc. MUDr. Radim Jančálek, Ph.D., MUDr. Martin Bulik, MUDr. Tomáš Kazda
(5/2016, Main topic ) - Safety aspects of treating relapsing-remitting multiple sclerosis
MUDr. Radek Ampapa, MUDr. Stanislav Kopecký
(5/2016, Review articles ) - Current strategy for treatment of high-grade gliomas
prof. MUDr. Pavel Šlampa, CSc., doc. MUDr. Radim Jančálek, Ph.D., MUDr. Tomáš Kazda, MUDr. Petr Pospíšil
(5/2016, Main topic ) - Importance of early diagnosis and treatment in the life perspective of patients with multiple sclerosis
doc. MUDr. Jan Mareš, Ph.D.
(5/2012, Review articles ) - Autoimunitní onemocnění centrálního nervového systému u dětí: současný pohled a terminologie
MUDr. Zuzana Libá, Ph.D.
(2/2018, Main topic ) - Monoklonální protilátky v léčbě roztroušené sklerózy
MUDr. Marek Peterka , MUDr. Zdeněk Kasl, Ph.D.
(2/2018, Pharmacotherapy ) - Magnetic resonance imaging for detection of opportunistic infection of patients with multiple sclerosis
doc. MUDr. Dana Horáková, Ph.D., prof. MUDr. Manuela Vaněčková, Ph.D.
(6/2016, Review articles ) - Old and new diagnostic criteria for Alzheimer’s disease in the conditions of the Czech Republic
doc. MUDr. Roman Jirák, CSc.
(2/2011, From the boundary of neurology ) - Neurofilament light chain and disease activity in patients with multiple sclerosis
doc. MUDr. Jarmila Szilasiová, PhD., MUDr. Miriam Fedičová
(3/2021, Review articles ) - Polyneuropathies in industrial neurology
doc. MUDr. Edvard Ehler, CSc.
(4/2013, Review articles ) - VYŠETŘENÍ ČICHU A JEHO VÝZNAM PRO DIAGNOSTIKU NEURODEGENERATIVNÍCH ONEMOCNĚNÍ
MUDr. Martin Vyhnálek , Ph.D., MUDr. Hana Magerová, PhD., MUDr. Jan Laczó, MUDr. Jakub Hort, Ph.D., doc. MUDr. Martin Bojar, CSc.
(1/2008, Review articles ) - Ocrelizumab is dampening the harm inflammation in patients with multiple sclerosis with little impact on protective immunity
prof. RNDr. Jan Krejsek, CSc.
(3/2020, From the boundary of neurology ) - Value of OCT‑A in patients with multiple sclerosis
MUDr. Miriama Skirková, PhD., MUDr. Monika Moravská, MUDr. Marek Horňák, MUDr. Jozef Szilasi, doc. MUDr. Jarmila Szilasiová, PhD.
(2/2023, Main topic ) - Časná stadia demence – možnosti diagnostiky a léčby
as. MUDr. Jakub Hort, Ph.D., MUDr. Martin Vyhnálek, doc. MUDr. Martin Bojar, CSc.
(6/2005, Review articles ) - Some biological and biochemical markers of multiple sclerosis
MUDr. Daniel Čierny, prof. MUDr. Egon Kurča, PhD., MUDr. Jozef Michalik, prof. RNDr. Ján Lehotský, DrSc.
(2/2014, Main topic ) - Magnetic resonance and sclerosis multiplex
MUDr. Víťazoslav Belan, PhD., MUDr. Monika Daňová
(2/2014, Main topic ) - Diagnostic imaging in hydrocephalus
MUDr. Václav Vybíhal, Ph.D., MUDr. Miloš Keřkovský, Ph.D., MUDr. Ivana Červinková, MUDr. Barbora Jurová, doc. MUDr. Marek Mechl, Ph.D., MBA
(4/2016, Main topic ) - The concept of mild cognitive impairment in Alzheimer’s disease and Parkinson’s disease
doc. MUDr. Irena Rektorová, Ph.D.
(6/2010, Review articles ) - The importance of magnetic resonance imaging in monitoring of disease activity of multiple sclerosis – a clinical neurologist insight
doc. MUDr. Manuela Vaněčková, Ph.D., MUDr. Dana Horáková, Ph.D.
(6/2012, Review articles ) - Alzheimer’s disease as a neuropathological continuum in clinical practice. How did we improve the diagnosis since 1984 and why we don’t have a causal therapy yet?
MUDr. Kateřina Sheardová, MUDr. Daniel Hudeček, MUDr. Olga Hromková, Ph.D., Rafal Marciniak, prof. MUDr. Jakub Hort, Ph.D.
(4/2016, Review articles ) - MR monitoring of activity of multiple sclerosis patients: conventional techniques and long-term MR monitoring of ocrelizumab therapy
prof. MUDr. Manuela Vaněčková, Ph.D.
(6/2019, From the boundary of neurology ) - New clinical criteria for diagnosing Alzheimer,s disease after 27 years
doc. MUDr. Irena Rektorová, Ph.D.
(2/2012, Main topic ) - Practical experience with laboratory diagnosis of Alzheimer's disease using tau protein, phospho-tau protein, and beta amyloid in cerebrospinal fluid
MUDr. Martina Koudelková
(5/2009, Main topic )
- Neurologic symptoms of mitochondrial diseases
doc. MUDr. Pavol Sýkora, CSc., MUDr. Miriam Kolníková
(6/2009, Review articles ) - ADHD ve světle současné psychiatrie a klinické praxe
doc. MUDr. Libuše Stárková, CSc.
(3/2018, Review articles )
- What’s new in immunotherapy for non-small cell lung cancer?
MUDr. Zuzana Pribulová
(1/2021, Main topic ) - News in the treatment of lung cancer
doc. MUDr. Peter Beržinec, CSc.
(4/2012, Review articles ) - Primary myelofibrosis – current view of pathophysiology, prognosis and treatment
Prof. MUDr. Elena Tóthová, CSc., MUDr. Adriana Kafková, PhD.
(5/2018, Spectrum ) - Therapeutical management in high-grade gliomas
MUDr. Elena Bolješíková, CSc., MUDr. Martin Chorváth, PhD.
(5/2016, Main topic ) - Systemic treatment of high-grade gliomas relapse or progression
MUDr. Bc. Patrik Palacka, PhD., MPH, MBA
(5/2016, Main topic ) - New approaches in the testing of HER2 status in the biopsies of breast carcinoma patients
prof. MUDr. Lukáš Plank, CSc.
(2/2024, Review articles ) - Tyrosine kinase inhibitor sunitinib malate
MUDr. Patrick Palacka, PhD., MPH, MBA
(3/2013, Drugs & drug classes ) - Current options in the treatment of HER2 low metastatic breast cancer
MUDr. Radovan Barila, PhD.
(2/2024, Review articles ) - 12th Central European Lung Cancer Conference
doc. MUDr. Peter Beržinec, CSc.
(1/2011, Events ) - Biomarkers in ovarian malignant tumors: state of the art
MUDr. Dávid Martinický, RNDr. Milan Zvarík, PhD.
(3/2014, Review articles ) - Personalized medicine approach in metastatatic colorectal cancer
MUDr. Vanda Ušáková, PhD.
(6/2013, Review articles ) - Classical and new prognostic factors and their impact on therapeutic procedures in DLBCL
doc. MUDr. Igor Andrašina, CSc., MUDr. Martin Petrilák
(3/2015, Spectrum ) - Review of of pharmacotherapy of metastatic melanoma
MUDr. Slavomír Urbanček, PhD.
(6/2016, Main topic ) - Immune checkpoint inhibitors in non-small cell lung cancer therapy
MUDr. Mária Černá, CSc.
(6/2015, Main topic ) - Inflammatory breast cancer
doc. MUDr. Mária Wagnerová, CSc.
(2/2012, Main topic ) - Novinky zo San Antonio Breast Cancer Symposium
prof. MUDr. Stanislav Špánik, CSc., MUDr. Vladimír Malec, PhD., MUDr. Mária Rečková
(1/2013, Events ) - Správa z Best of ASCO® Slovakia 2015
MUDr. Mária Rečková
(6/2015, Events ) - Clinical significance of PD-L1 immune check-point measurement
MUDr. Peter Kasan
(2/2017, Drugs & drug classes ) - Chemotherapy for colorectal cancer
MUDr. Zuzana Hlavatá
(6/2009, Review articles ) - Immunotherapy and targeted treatment for metastatic, castration-resistant prostate cancer
MUDr. Ján Slopovský, JUDr. MUDr. Patrik Palacka, PhD., MPH, MBA, LL.M.
(4/2022, Main topic ) - Zaujímavosti z literatúry: Analýzy biomarkerov a definitívne výsledky celkového prežitia z randomizovanej, otvorenej, prvolíniovej štúdie gefitinib verzus karboplatina/paklitaxel u klinicky vybraných pacientov s pokročilým nemalobunkovým karcinómom pľúc v
Editor rubriky: doc. MUDr. Peter Beržinec, CSc.
(3/2011, Information & comments ) - Diagnostic and prognostic factors in multiple myeloma
MUDr. Zdenka Štefániková
(3/2016, Spectrum ) - Neuroendocrine tumors from oncologist's point of view
doc. MUDr. Mária Wagnerová, CSc.
(4/2011, Review articles ) - Metronomic chemotherapy – promising therapeutical approach for recurrent/ refractory high risk tumours in children
MUDr. Irina Oravkinová, MUDr. Ladislav Deák, MUDr. Jaroslava Feketeová, MUDr. Viktória Halušková, MUDr. Ivana Senčáková, MUDr. Igor Jenčo
(5/2011, Original articles & case reports ) - Systemic treatment of bladder cancer – neoadjuvant, adjuvant and palliative chemotherapy
MUDr. Branislav Bystrický, MUDr. Filip Kohútek, MUDr. Peter Kohútek, MUDr. Tomáš Sedláček
(3/2016, Review articles ) - Can we expect „ A new era“ in melanoma?
MUDr. Zuzana Hlavatá
(5/2011, Review articles ) - The present approach to treatment of renall cell carcinoma
MUDr. Zuzana Syčová-Milá
(5/2010, Review articles ) - The combination of cetuximab and radiotherapy in the first line treatment of colorectal carcinoma – The Slovak project
MUDr. Tomáš Šálek, MUDr. Marián Streško, MUDr. Jozef Chovanec, MUDr. Eduard Šebo, MUDr. Dagmar Mazalová, MUDr. Alena Thomková, a ďalší
(5/2010, Original articles & case reports ) - Role of pathologist in the diagnosis of cancer of unknown primary origin
doc. MUDr. Karol Kajo, PhD.
(4/2013, Main topic ) - Správy z podujatia ASCO Chicago 2014
prof. MUDr. Stanislav Špánik, CSc., MUDr. Mária Rečková, MUDr. Patrik Palacka, PhD. MPH, MBA
(4/2014, Events ) - Pokrok v imunoterapii malígneho melanómu a karcinómu pľúc inhibítormi imunitných kontrolných bodov
MUDr. Róbert Godál
(2/2018, Main topic ) - New research and therapeutic targets in molecular genetics of tumors − our research potential
RNDr. Alena Gábelová, CSc., Mgr. Miroslav Chovanec, PhD., RNDr. Ján Sedlák, DrSc., Mgr. Lucia Kučerová, PhD., RNDr. Božena Smolková, PhD., Mgr. Viera Kajabová, PhD., RNDr. Ivana Fridrichová, CSc.
(1/2015, Main topic ) - Dual inhibition after failure of NSAI as a solution to hormone therapy resistance
MUDr. Bibiána Vertáková Krakovská, PhD.
(1/2015, Review articles ) - Increased production of HE4 by tumour tissues and its importance of measurement in patients with malignant tumours
MUDr. Jaroslav Weissensteiner, doc. Mgr. Eva Babušíková, PhD.
(1/2015, Review articles ) - Optimal management of patients with breast cancer after progression on CDK4/6 inhibitors.
MUDr. Filip Kohútek, PhD., MUDr. Branislav Bystrický, PhD., MPH
(2/2022, Main topic ) - Publikujeme v zahraničí
redakcia
(3/2018, Information & comments ) - Molecular biology of colorectal cancer from the perspective of the pathologist
MUDr. Michal Kalman
(5/2014, Main topic ) - Ipilimumab – new drug, new experience
MUDr. Zuzana Hlavatá, PhD.
(5/2013, Original articles & case reports ) - Advances in the systemic treatment of non-small cell lung cancer
MUDr. Mária Černá, CSc.
(2/2023, Main topic ) - Exosomes – new topic in diagnostics of cancer
RNDr. Ján Sedlák, DrSc., Mgr. Martina Zdurienčíková, RNDr. Paulína Gronesová, PhD., RNDr. Dana Cholujová, PhD., RNDr. Ľuba Hunáková, CSc.
(5/2015, Review articles ) - Publikujeme v zahraničí
(1/2016, Information & comments ) - Molecular pathology of diffuse large B-cell lymphoma – a review
prof. MUDr. Lukáš Plank, CSc., MUDr. Tomáš Balhárek, PhD., MUDr. Jozef Mičák
(2/2015, Spectrum ) - Utilisation of immunochemical methods and molecular genetics in monitoring patients with cervical cancer
prof. MUDr. Dalibor Ondruš, DrSc., MUDr. Peter Babala, MUDr. Miroslav Klačko, MUDr. Peter Mikloš, MUDr. Ladislav Masák, CSc., RNDr. Eva Weismanová, PhD.
(4/2010, Original articles & case reports ) - Optimal first-line treatment of mCRC
MUDr. Jana Ďurková
(1/2017, Review articles ) - VI. Bardejovské onkologické dni
MUDr. Jozef Chovanec
(4/2010, Events ) - Palbociclib in the treatment of advanced breast cancer
MUDr. Branislav Bystrický
(1/2017, Drugs & drug classes ) - PROSTATE SPECIFIC ANTIGEN (PSA) – SITUATION IN THE YEAR 2007
MUDr. Ivan Kolombo, FEBU, MUDr. Martina Poršová, MUDr. Iva Zemanová, MUDr. Miloš Horecký, MUDr. Petra Antonová, MUDr. Tomáš Vlásek, MUDr. Jaroslav Porš
(6/2007, Review articles ) - Immunohistochemical expression of PD-L1 in biopsy specimen: how and why to examine?
prof. MUDr. Lukáš Plank, CSc.
(6/2018, Main topic ) - Systemic treatment of metastatic renal cell carcinoma after failure of the first line of treatment
MUDr. Dagmar Sudeková
(1/2018, Main topic ) - Smoldering multiple myeloma
prof. MUDr. Elena Tóthová, CSc.
(2/2016, Spectrum ) - SHOX2 gene methylation as a diagnostic marker of lung cancer
RNDr. Michal Konečný, PhD., Mgr. Lenka Dolešová, doc. RNDr. Iveta Waczulíková, PhD., doc. MUDr. Ivan Majer, CSc., Mgr. Ján Markus, PhD.1, MUDr. Helena Novosadová
(2/2016, Original articles & case reports ) - Nintendanib – new triple inhibitor of angiokinases in 2nd line of NSCLC
MUDr. Zuzana Pribulová
(2/2016, Drugs & drug classes ) - Prognostické faktory pri chronickej lymfocytovej leukémii
MUDr. Ľudmila Demitrovičová, PhD.
(4/2018, Review articles )
- Review of of pharmacotherapy of metastatic melanoma
MUDr. Slavomír Urbanček, PhD.
(4/2016, Topic of the year ) - Seborrheic dermatitis
MUDr. Milan Junášek
(2/2015, Review articles ) - Ki-67 antigen and p53 protein expression in basal cell carcinoma of the skin – a topic review
MUDr. Milada Kullová, MUDr. Vladimír Bartoš, PhD.
(2-3/2013, Review articles ) - Immunohistochemical expression of smooth muscle actin in basal cell carcinoma of the skin
MUDr. Jana Doboszová, MUDr. Vladimír Bartoš, PhD.
(3/2014, Original articles & case reports ) - News in genetic diagnosis of malignant melanoma
RNDr. Lucia Tatayová, MUDr. Michaela Dubčeková, RNDr. Renáta Lukačková, PhD., Prof. MUDr. Beata Mladosievičová, CSc.
(4/2022, Review articles )
- ADHD ve světle současné psychiatrie a klinické praxe
MUDr. Libuše Stárková, CSc.
(2/2018, Current pharmacotherapy )
- XXI. SLOVENSKO-ČESKÁ KONFERENCIA O HEMOSTÁZE A TROMBÓZE S MEDZINÁRODNOU ÚČASŤOU
(S2/2014, Supplement )
- Acute renal insufficiency in surgical patients
prof. MUDr. RNDr. Rudolf Pullmann, PhD., MUDr. Ivana Daňová, doc. MUDr. Dušan Mištuna, PhD., mim. prof.
(3/2014, Review articles )
- Coagulopathy associated with COVID - 19 infection Safe and effective thromboprophylaxis is essential for patient survival
MUDr. Ľubomíra Romanová, PhD., MUDr. Erika Palenčíková, MUDr. Kováč Martin
(1/2021, Review articles ) - Vplyv celkovej anestézie, veku a systémového zápalu na neuropsychologické funkcie u onkochirurgických pacientov
MUC. Patrícia Vargová, doc. MUDr. Roman Záhorec, CSc., Mgr. Lucia Alakšová, MUDr. Daniel Cintula, MUDr. Vítězoslav Marek, PhD., MUDr. Martin Sabol, PhD.
(1/2018, Original articles ) - Prečo treba sledovať diferencovaný obraz bielych krviniek – zvlášť pomer počtu neutrofilných granulocytov k počtu lymfocytov?
doc. MUDr. Roman Záhorec, CSc.
(1/2014, Editorial )
- Serum level of microRNA miR-371a-3p as a biomarker in the management of testicular germ cell tumours
RNDr. Imrich Hikkel, PhD., RNDr. Barbora Michalíková, RNDr. Ing. Katarína Kaľavská, PhD., Ing. Martin Čermák, prof. MUDr. Michal Mego, DrSC.
(1/2024, Original articles & case reports ) - Contemporary approaches to genetic diagnostics in clinical oncology
RNDr. Regína Lohajová Behulová, PhD., Mgr. Michal Svoboda, RNDr. Aster Alemayehu, PhD., Mgr. Lukáš Šebest, PhD.
(2/2024, Main topic )